Brief: Lavipharm H1 Net Profit Down To EUR 1.9 Million
15/09/2022 16:54
Sept 15 (Reuters) - Lavipharm SA LPHr.AT :
* H1 SALES EUR 21.2 MILLION VERSUS EUR 19.6 MILLION YEAR AGO
* H1 EBITDA EUR 3.9 MILLION VERSUS EUR 4.9 MILLION YEAR AGO
* H1 NET PROFIT AFTER MINORITIES EUR 1.9 MILLION VERSUS EUR
2.6
MILLION YEAR AGO
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY